OncoPharm cover image

Carboplatin Paclitaxel in Ovarian Cancer

OncoPharm

00:00

Trial Population and Eligibility

John Bazar describes the study's selection of optimally debulked stage III ovarian cancer patients and surgical requirements.

Play episode from 03:16
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app